Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 53079 [2021-20802]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices
IV. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third-party disclosure requirements
under the Paperwork Reduction Act of
1995 (PRA). However, section III of this
document does contain a general
solicitation of comments in the form of
a request for information. In accordance
with the implementing regulations of
the PRA, specifically 5 CFR
1320.3(h)(4), this general solicitation is
exempt from the PRA. Facts or opinions
submitted in response to general
solicitations of comments from the
public, published in the Federal
Register or other publications,
regardless of the form or format thereof,
provided that no person is required to
supply specific information pertaining
to the commenter, other than that
necessary for self-identification, as a
condition of the agency’s full
consideration, are not generally
considered information collections and
therefore not subject to the PRA.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the PRA.
V. Response to Comments
Because of the large number of public
comments we normally receive in
response to Federal Register
documents, we are not able to
acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, if we proceed with
a subsequent document, we may
respond to the comments in the
preamble to that document. Publication
of this RFI does not commit OIG to the
promulgation of new regulations or
issuance of new guidance.
Christi A. Grimm,
Principal Deputy, Inspector General.
[FR Doc. 2021–20558 Filed 9–23–21; 8:45 am]
BILLING CODE 4152–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on
SUMMARY:
VerDate Sep<11>2014
16:50 Sep 23, 2021
Jkt 253001
November 8, 2021. The topic for this
meeting will be ‘‘Evolving Concepts in
the Assessment and Management of
Hypoglycemia.’’ The meeting is open to
the public.
DATES: The meeting will be held on
November 8, 2021 from 12:00 p.m. to
3:00 p.m. EDT.
ADDRESSES: The meeting will be held
via the Zoom online video conferencing
platform. For details, and to register,
please contact dmicc@mail.nih.gov.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, including a draft agenda,
which will be posted when available,
see the DMICC website,
www.diabetescommittee.gov, or contact
Dr. William Cefalu, Executive Secretary
of the Diabetes Mellitus Interagency
Coordinating Committee, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy
Boulevard, Democracy 2, Room 6037,
Bethesda, MD 20892, telephone: 301–
435–1011; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with 42 U.S. Code § 285c–3,
the DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
November 8, 2021 DMICC meeting will
focus on ‘‘Evolving Concepts in the
Assessment and Management of
Hypoglycemia.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 5
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
53079
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
website, www.diabetescommittee.gov.
Dated: September 21, 2021.
Bruce Tibor Roberts,
Health Science Policy Analyst, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2021–20802 Filed 9–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Initial Review Group; Mental
Health Services Study Section.
Date: October 21–22, 2021.
Time: October 21, 2021, 12:00 p.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Time: October 22, 2021, 11:00 a.m. to 4:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Aileen Schulte, Ph.D.,
Scientific Review Officer, Division of
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 86, Number 183 (Friday, September 24, 2021)]
[Notices]
[Page 53079]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20802]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on November 8, 2021. The topic for this
meeting will be ``Evolving Concepts in the Assessment and Management of
Hypoglycemia.'' The meeting is open to the public.
DATES: The meeting will be held on November 8, 2021 from 12:00 p.m. to
3:00 p.m. EDT.
ADDRESSES: The meeting will be held via the Zoom online video
conferencing platform. For details, and to register, please contact
[email protected].
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, including a draft agenda, which will be posted when
available, see the DMICC website, www.diabetescommittee.gov, or contact
Dr. William Cefalu, Executive Secretary of the Diabetes Mellitus
Interagency Coordinating Committee, National Institute of Diabetes and
Digestive and Kidney Diseases, 6707 Democracy Boulevard, Democracy 2,
Room 6037, Bethesda, MD 20892, telephone: 301-435-1011; email:
[email protected].
SUPPLEMENTARY INFORMATION: In accordance with 42 U.S. Code Sec. 285c-
3, the DMICC, chaired by the National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) comprising members of the
Department of Health and Human Services and other federal agencies that
support diabetes-related activities, facilitates cooperation,
communication, and collaboration on diabetes among government entities.
DMICC meetings, held several times a year, provide an opportunity for
Committee members to learn about and discuss current and future
diabetes programs in DMICC member organizations and to identify
opportunities for collaboration. The November 8, 2021 DMICC meeting
will focus on ``Evolving Concepts in the Assessment and Management of
Hypoglycemia.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 5 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC website, www.diabetescommittee.gov.
Dated: September 21, 2021.
Bruce Tibor Roberts,
Health Science Policy Analyst, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2021-20802 Filed 9-23-21; 8:45 am]
BILLING CODE 4140-01-P
